← Back to Search

Interdisciplinary Clinic for Parkinson's Disease

N/A
Waitlist Available
Led By Christine M Clarkin, PhD
Research Sponsored by University of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study - 2 months
Awards & highlights

Study Summary

This trial tests a new model of healthcare for Parkinson's patients, with 20 people attending "boot camp" sessions for 3 sessions & 2 months follow-up. It will assess how well it works & how patients experience it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study - 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study - 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Health Education Impact Questionnaire
Change in Parkinson's Disease Knowledge Questionnaire
Change in Patient Centered Outcome Questionnaire
+2 more
Secondary outcome measures
Change in Self-Efficacy for Exercise
Change in balance confidence measured with the Activities-specific Balance Confidence (ABC) Scale.
Change in quality of life measured with the Parkinson Disease Questionnaire-39 (PDQ-39)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: EMPOWER PD Clinic ParticipationExperimental Treatment1 Intervention
All participants will be assigned to the same interdisciplinary clinic and educational intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Interdisciplinary Clinic
2023
N/A
~20

Find a Location

Who is running the clinical trial?

University of Rhode IslandLead Sponsor
52 Previous Clinical Trials
22,171 Total Patients Enrolled
Brown UniversityOTHER
456 Previous Clinical Trials
563,061 Total Patients Enrolled
Christine M Clarkin, PhDPrincipal InvestigatorUniversity of Rhode Island

Media Library

Interdisciplinary Clinic Clinical Trial Eligibility Overview. Trial Name: NCT05640167 — N/A
Parkinson's Disease Research Study Groups: EMPOWER PD Clinic Participation
Parkinson's Disease Clinical Trial 2023: Interdisciplinary Clinic Highlights & Side Effects. Trial Name: NCT05640167 — N/A
Interdisciplinary Clinic 2023 Treatment Timeline for Medical Study. Trial Name: NCT05640167 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do the protocols for this experiment permit participants of advanced age?

"The trial's requirements are that potential participants should be between 40 and 100 years old. Meanwhile, 27 trials have been created for those younger than 18 while 489 studies exist to research the elderly population."

Answered by AI

Are there any remaining openings for prospective participants in this trial?

"As indicated on clinicaltrials.gov, this trial is not actively searching for candidates at the moment. Originally posted 12/1/2022 and last updated on 12/6/2022, potential test subjects should be aware that 492 other studies are presently enrolling patients."

Answered by AI

What is the ultimate goal of this experiment?

"The primary outcome of this clinical trial, assessed over a two month period, is the program survey's feasibility. Secondary outcomes include changes in quality of life (measured with the [Parkinson disease](https://www.withpower.com/clinical-trials/parkinson-disease) Questionnaire-39), balance confidence (using the Activities-specific Balance Confidence Scale) and fatigue levels (assessed via the Parkinson's Fatigue Scale)."

Answered by AI

Who is eligible to enrol in this scientific experiment?

"This experimental trial is inviting 20 individuals aged 40 to 100 years old with confirmed Parkinson disease diagnoses, that are not institutionalized."

Answered by AI
~10 spots leftby Apr 2025